Aigen Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,283
| Closed | -$213K | – | 942 |
|
|
2024
Q4 | $213K | Buy |
+18,283
| New | +$213K | 0.04% | 593 |
|
|
2023
Q4 | – | Sell |
-17,569
| Closed | -$556K | – | 985 |
|
|
2023
Q3 | $556K | Buy |
+17,569
| New | +$556K | 0.1% | 318 |
|
|
2023
Q1 | – | Sell |
-10,383
| Closed | -$362K | – | 754 |
|
|
2022
Q4 | $362K | Buy |
+10,383
| New | +$362K | 0.05% | 328 |
|
|
2022
Q2 | – | Sell |
-9,233
| Closed | -$671K | – | 669 |
|
|
2022
Q1 | $671K | Buy |
+9,233
| New | +$671K | 0.12% | 232 |
|
|
2021
Q2 | – | Sell |
-5,093
| Closed | -$409K | – | 651 |
|
|
2021
Q1 | $409K | Sell |
5,093
-4,119
| -45% | -$331K | 0.05% | 340 |
|
|
2020
Q4 | $501K | Buy |
+9,212
| New | +$501K | 0.07% | 390 |
|
|
2020
Q3 | – | Sell |
-89,571
| Closed | -$1.88M | – | 1029 |
|
|
2020
Q2 | $1.88M | Buy |
89,571
+51,221
| +134% | +$1.08M | 0.24% | 107 |
|
|
2020
Q1 | $469K | Buy |
+38,350
| New | +$469K | 0.06% | 438 |
|